Evidence map›Paper›PMID 40900850›Full record

ArticleWorld journal of methodology2025

Imaging findings of irritable bowel syndrome patients, and the diagnostic value of irritable bowel syndrome: A systematic review.

Hyder Osman Mirghani

Abstract read
In one paragraph

Article in World journal of methodology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Hyder Osman MirghaniDepartment of Internal Medicine, University of Tabuk, Saudi Arabia, Tabuk 51941, Saudi Arabia. s.hyder63@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIrritable bowel syndrome (IBS) is a prevalent functional gastrointestinal (FGITD) disorder, the diagnosis is based on Rome Criteria and other subjective tools. Because IBS overlaps with other FGITD and organic diseases, and the subjective tools do not apply to patients with cognitive decline, objective diagnostic tools are important in this category of patients.

aimTo discuss the role of imaging in IBS diagnosis.

methodsWe systematically searched three databases for articles published in the English language with no limitation to a specific period. The literature search was conducted in June and July 2024. The keywords used are IBS and functional bowel disorders, computed tomography, Magnetic Resonance Imaging, functional brain magnetic resonance imaging (MRI), and static brain MRI, and were linked with the terms

resultsMagnetic resonance imaging is superior due to its sensitivity, lack of radiation exposure, and lack of need for bowel preparation. Patients with IBS had smaller colonic and rectal volumes compared to healthy controls and functional constipation. Dynamic and static Magnetic Resonance Imaging of the brain showed increased activity, thinning, and increased volumes in specific areas of pain modulation. The above abnormalities are not uniform and vary significantly according to the type of IBS, the duration and intensity of symptoms, gender, and culture.

conclusionMagnetic resonance imaging shows smaller colonic and rectal volumes, and increased activity, thinning, and increased volumes in specific areas of pain modulation. Large trials incorporating all above limitations are needed.

Indexed as

Computed tomographyDiagnosisIrritable bowel syndromeMagnetic resonance imagingUltrasound

Identifiers

PMID40900850
PMCPMC12400319

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.